Over the previous few years, there was a gradual inflow of startups making an attempt to deal with points like despair, interval ache, PMS, nervousness and insomnia through the use of wearables that apply electrical, magnetic or ultrasonic alerts to stimulate the mind.
San Francisco-based Mave Health is the newest of that fleet, and claims its $495, neuromodulation headset can enhance consideration and temper, regulate stress, and even measure psychological well being. The startup is positioning the wearable as a non-medical gadget so it gained’t want clearance from companies just like the U.S. Food and Drug Administration (FDA) to promote within the U.S.
Dhawal Jain, who began the corporate in 2023 together with his faculty batch mates Jai Sharma (CMO) and Aman Kumar (CTO), stated he realized the necessity for such a tool after his flatmate’s fiancée dedicated suicide through the COVID-19 pandemic lockdowns.
“In India, committing suicide is a criminal offense, which meant there was police concerned, and we needed to converse to her psychologist. The solutions we bought from them made us query if any of it made sense. We began connecting with different psychologists and have been getting the identical solutions,” Jain stated.
The founders felt that there was no tangible strategy to measure progress within the psychological well being area. “For instance, for those who ask a psychologist how have you learnt if an individual is making progress, their response to it is vitally customary, which is that it’s not about progress. It’s about course of […] But for someone with despair who’s spending a variety of time in remedy, progress is vital. So how have you learnt whether or not they’re making progress or not? And even these primary questions weren’t being answered.”
In an effort to unravel that, the group began to study extra about neuroscience by speaking to consultants, and shortly after realized that whereas there was progress round neuromodulation in labs, customers haven’t had the good thing about it.
The firm then labored with medical gadget and psychological well being consultants to conduct trials of the expertise. But finally it took a unique route and positioned its headset as a way of life gadget. Jain stated this method would let Mave attain a wider viewers.
Techcrunch occasion
San Francisco, CA
|
October 13-15, 2026
The gadget and expertise
Mave Health’s gadget employs transcranial direct present stimulation (tDCS), a non-invasive approach to manage low-intensity currents to the mind to fireside up neurons. The approach is typically utilized in psychology, and is claimed to be secure. Side results are gentle and short-term, like itching or discomfort.
The headset delivers a low 1-2 mA present to stimulate the mind. The startup says prospects can use the gadget, which weighs roughly 100 grams, anytime, and recommends day by day classes spanning 20 minutes for the primary few weeks of utilization.
The startup additionally supplies an app that may measure long-term developments in temper, focus and stress ranges. It may combine with different well being information and observe measures like Heart Rate Variability (HRV). Jain stated customers begin with a self-reported baseline evaluation after they begin, and full follow-up assessments each two to 4 weeks, which helps Mave perceive if the gadget helps a consumer in the long run.
The firm hasn’t carried out any medical trials or printed any research but. However, Jain says it labored with greater than 500 customers in a non-public beta in 2024 and 2025, throughout which eight in ten customers reported a 60% enhance in productiveness. The startup famous that 75% of its non-public beta customers additionally reported a discount in stress from their baseline inside two months of utilization.
Mave Health stated it has carried out 4 observational research throughout 200 contributors which are below tutorial assessment with an purpose to publish this 12 months.
Dr. Himanshu Nirvan, a Delhi-based psychiatrist who labored with Mave Health as a guide, stated that tDCS-based gadgets are thought-about a confirmed strategy to tackle psychological health-related points. However, he famous that he hasn’t regarded on the expertise from a way of life lens.
The firm says it ran a program in India with Dr. Nirvan to check the gadget and the expertise.
“We did choose a variety of sufferers, and it was basically program in my view. Things like which are typically not very ceaselessly and simply obtainable even within the psychological well being administration area,” Dr. Nirvan stated. “I felt that for lots of people, tDCS is definitely fairly modality, contemplating that it’s a really transportable gadget. You can basically cost it at dwelling, take it anyplace you need, even when you’re touring.”
Leigh Elkin Charvet, a medical neuropsychologist and Professor of Neurology at NYU Grossman School of Medicine, instructed TechCrunch over electronic mail that whereas tDCS is taken into account a secure and efficient method to neuromodulation, gadgets must be designed effectively to align electrodes correctly, and customers have to have common and constant classes.
“One problem is that buyers could use the gadget with out medical screening or clear steering about whether or not it’s applicable for his or her signs. Another is that it may be troublesome for customers to find out whether or not the gadget is definitely serving to if outcomes are usually not being measured in a structured manner,” she stated.
Charvet added that using tDCS for broad way of life enhancement in wholesome people has not been studied broadly. “So far, a lot of the strongest analysis has targeted on medical populations or structured cognitive coaching paradigms. We don’t but have clear steering or robust proof supporting using tDCS to enhance efficiency in in any other case wholesome people. A life-style use case should emerge, however that can depend on clearly defining goal outcomes and demonstrating that results are measurable and reproducible,” she stated.
The gadget is presently obtainable for pre-order, and the corporate is aiming to ship its first batch to prospects within the U.S. and India in April 2026.
The firm not too long ago raised $2.1 million in a seed funding spherical led by Blume Ventures, with participation from particular person traders who embody Tesla Autopilot AI lead Dhaval Shroff. The startup has raised just below $3 million in funding up to now.
